A phase 2 study of IMC-A12 (NSC742460) in hepatocellular carcinoma

Trial Profile

A phase 2 study of IMC-A12 (NSC742460) in hepatocellular carcinoma

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Jul 2014

At a glance

  • Drugs Cixutumumab (Primary)
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Feb 2011 Actual end date (February 2011) added as reported by ClinicalTrials.gov.
    • 23 Feb 2011 Status changed from suspended to completed as reported by ClinicalTrials.gov.
    • 12 Jun 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top